Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Central nervous system neoplasm
ADR ID BADD_A00831
ADR Hierarchy
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.01      Nervous system neoplasms unspecified malignancy NEC
17.20.01.001      Central nervous system neoplasm
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.01      Nervous system neoplasms unspecified malignancy NEC
16.30.01.001      Central nervous system neoplasm
Description Not Available
MedDRA Code 10007958
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Central nervous system neoplasm | Central nervous system neoplasm NOS | CNS neoplasia | CNS neoplasm | CNS neoplasm NOS | Neoplasm CNS | Neoplasm of uncertain behavior of brain and spinal cord | Neoplasm of uncertain behaviour of brain and spinal cord
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00950Fluvoxamine--
BADD_D00981Gabapentin--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01136Imatinib0.000112%
BADD_D01506Muromonab-cd3--
BADD_D01507Mycophenolate mofetil--
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01835Pregabalin--
BADD_D02002Selegiline--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
The 1th Page    1    Total 1 Pages